Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohanraj Ramachandran

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
EMBO Molecular Medicine|May 19, 2016
Safe engineering of CAR T cells for adoptive cell therapy of cancer using long-term episomal gene transferChuan Jin, Grammatiki Fotaki, Mohanraj Ramachandran, et al.
Molecular Therapy Oncolytics|June 18, 2021
Concurrent expression of <i>HP-NAP</i> enhances antitumor efficacy of oncolytic vaccinia virus but not for Semliki Forest virusJing Ma, Chuan Jin, Matko Čančer, et al.
Frontiers in Immunology|September 20, 2021
Tertiary Lymphoid Structures in the Central Nervous System: Implications for GlioblastomaTiarne van de Walle, Alessandra Vaccaro, Mohanraj Ramachandran, et al.
Cell Death & Disease|January 24, 2020
Characterization of virus-mediated immunogenic cancer cell death and the consequences for oncolytic virus-based immunotherapy of cancerJing Ma, Mohanraj Ramachandran, Chuan Jin, et al.
Oncoimmunology|February 6, 2018
Pro-inflammatory allogeneic DCs promote activation of bystander immune cells and thereby license antigen-specific T-cell responsesGrammatiki Fotaki, Chuan Jin, Mohanraj Ramachandran, et al.
Cancer Gene Therapy|May 20, 2022
Ixovex-1, a novel oncolytic E1B-mutated adenovirusMohiemen Anwar, Maja-Louise Arendt, Mohanraj Ramachandran, et al.
Journal for Immunotherapy of Cancer|May 19, 2025
Brain tumors induce immunoregulatory dendritic cells in draining lymph nodes that can be targeted by OX40 agonist treatmentOscar Badillo-Godinez, Jenni Niemi, Liam Helfridsson, et al.
Molecular Cancer Therapeutics|October 29, 2025
Shaping Tumor Microenvironment by Amplifying the Complement Cascade for Improved Immune Response in Pancreatic Cancer ModelMenghan Gao, Soultana Kechagia, Mohanraj Ramachandran, et al.
Molecular Therapy Oncolytics|April 19, 2021
IFN-I-tolerant oncolytic Semliki Forest virus in combination with anti-PD1 enhances T cell response against mouse gliomaMiika Martikainen, Mohanraj Ramachandran, Roberta Lugano, et al.
Oncoimmunology|February 6, 2018
Cancer vaccine based on a combination of an infection-enhanced adenoviral vector and pro-inflammatory allogeneic DCs leads to sustained antigen-specific immune responses in three melanoma modelsGrammatiki Fotaki, Chuan Jin, Iliana Kyriaki Kerzeli, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
EMBO Molecular Medicine|May 19, 2016
Safe engineering of CAR T cells for adoptive cell therapy of cancer using long-term episomal gene transferChuan Jin, Grammatiki Fotaki, Mohanraj Ramachandran, et al.
Molecular Therapy Oncolytics|June 18, 2021
Concurrent expression of <i>HP-NAP</i> enhances antitumor efficacy of oncolytic vaccinia virus but not for Semliki Forest virusJing Ma, Chuan Jin, Matko Čančer, et al.
Frontiers in Immunology|September 20, 2021
Tertiary Lymphoid Structures in the Central Nervous System: Implications for GlioblastomaTiarne van de Walle, Alessandra Vaccaro, Mohanraj Ramachandran, et al.
Cell Death & Disease|January 24, 2020
Characterization of virus-mediated immunogenic cancer cell death and the consequences for oncolytic virus-based immunotherapy of cancerJing Ma, Mohanraj Ramachandran, Chuan Jin, et al.
Oncoimmunology|February 6, 2018
Pro-inflammatory allogeneic DCs promote activation of bystander immune cells and thereby license antigen-specific T-cell responsesGrammatiki Fotaki, Chuan Jin, Mohanraj Ramachandran, et al.
Cancer Gene Therapy|May 20, 2022
Ixovex-1, a novel oncolytic E1B-mutated adenovirusMohiemen Anwar, Maja-Louise Arendt, Mohanraj Ramachandran, et al.
Journal for Immunotherapy of Cancer|May 19, 2025
Brain tumors induce immunoregulatory dendritic cells in draining lymph nodes that can be targeted by OX40 agonist treatmentOscar Badillo-Godinez, Jenni Niemi, Liam Helfridsson, et al.
Molecular Cancer Therapeutics|October 29, 2025
Shaping Tumor Microenvironment by Amplifying the Complement Cascade for Improved Immune Response in Pancreatic Cancer ModelMenghan Gao, Soultana Kechagia, Mohanraj Ramachandran, et al.
Molecular Therapy Oncolytics|April 19, 2021
IFN-I-tolerant oncolytic Semliki Forest virus in combination with anti-PD1 enhances T cell response against mouse gliomaMiika Martikainen, Mohanraj Ramachandran, Roberta Lugano, et al.
Oncoimmunology|February 6, 2018
Cancer vaccine based on a combination of an infection-enhanced adenoviral vector and pro-inflammatory allogeneic DCs leads to sustained antigen-specific immune responses in three melanoma modelsGrammatiki Fotaki, Chuan Jin, Iliana Kyriaki Kerzeli, et al.
Pageof 3